Advertisement

Ads Placeholder
Loading...

NEXGEL, Inc.

NXGLNASDAQ
Healthcare
Medical - Instruments & Supplies
$0.61
$-0.01(-2.32%)
U.S. Market is Open • 10:37

NEXGEL, Inc. Fundamental Analysis

NEXGEL, Inc. (NXGL) shows weak financial fundamentals with a PE ratio of -1.55, profit margin of -26.27%, and ROE of -61.46%. The company generates $0.0B in annual revenue with weak year-over-year growth of 1.12%.

Key Strengths

PEG Ratio-0.02

Areas of Concern

ROE-61.46%
Operating Margin-29.35%
We analyze NXGL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -40.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-40.8/100

We analyze NXGL's fundamental strength across five key dimensions:

Efficiency Score

Weak

NXGL struggles to generate sufficient returns from assets.

ROA > 10%
-28.68%

Valuation Score

Excellent

NXGL trades at attractive valuation levels.

PE < 25
-1.55
PEG Ratio < 2
-0.02

Growth Score

Moderate

NXGL shows steady but slowing expansion.

Revenue Growth > 5%
1.12%
EPS Growth > 10%
10.71%

Financial Health Score

Excellent

NXGL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.67
Current Ratio > 1
1.47

Profitability Score

Weak

NXGL struggles to sustain strong margins.

ROE > 15%
-6145.97%
Net Margin ≥ 15%
-26.27%
Positive Free Cash Flow
No

Key Financial Metrics

Is NXGL Expensive or Cheap?

P/E Ratio

NXGL trades at -1.55 times earnings. This suggests potential undervaluation.

-1.55

PEG Ratio

When adjusting for growth, NXGL's PEG of -0.02 indicates potential undervaluation.

-0.02

Price to Book

The market values NEXGEL, Inc. at 1.04 times its book value. This may indicate undervaluation.

1.04

EV/EBITDA

Enterprise value stands at -1.08 times EBITDA. This is generally considered low.

-1.08

How Well Does NXGL Make Money?

Net Profit Margin

For every $100 in sales, NEXGEL, Inc. keeps $-26.27 as profit after all expenses.

-26.27%

Operating Margin

Core operations generate -29.35 in profit for every $100 in revenue, before interest and taxes.

-29.35%

ROE

Management delivers $-61.46 in profit for every $100 of shareholder equity.

-61.46%

ROA

NEXGEL, Inc. generates $-28.68 in profit for every $100 in assets, demonstrating efficient asset deployment.

-28.68%

Following the Money - Real Cash Generation

Operating Cash Flow

NEXGEL, Inc. generates limited operating cash flow of $-1.78M, signaling weaker underlying cash strength.

$-1.78M

Free Cash Flow

NEXGEL, Inc. generates weak or negative free cash flow of $-1.78M, restricting financial flexibility.

$-1.78M

FCF Per Share

Each share generates $-0.17 in free cash annually.

$-0.17

FCF Yield

NXGL converts -20.82% of its market value into free cash.

-20.82%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.55

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.04

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.55

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.67

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.47

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.61

vs 25 benchmark

ROA

Return on assets percentage

-0.29

vs 25 benchmark

ROCE

Return on capital employed

-0.45

vs 25 benchmark

How NXGL Stacks Against Its Sector Peers

MetricNXGL ValueSector AveragePerformance
P/E Ratio-1.5528.45 Better (Cheaper)
ROE-61.46%763.00% Weak
Net Margin-26.27%-45265.00% (disorted) Weak
Debt/Equity0.670.34 Weak (High Leverage)
Current Ratio1.472795.60 Neutral
ROA-28.68%-16588.00% (disorted) Weak

NXGL outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews NEXGEL, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

935.58%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-45.82%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-82.19%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ